Table 1.
Demographic and clinical characteristics of 110 participants.
| Characteristics (N = 110) | Value |
|---|---|
| Age, years | 57 (50–63) |
| Gender, Male/Female | 48/62 |
| BMI, kg/m2 | 24.69 ± 3.62 |
| Years of education, years | 9.0 (6.0–12.0) |
| Drinking, n (%) | 19 (17.3) |
| Smoking, n (%) | 23 (20.9) |
| Hypertension, n (%) | 29 (26.4) |
| Diabetes, n (%) | 11 (10.0) |
| Sleep medications, n (%) | 7 (6.4) |
| Antipsychotic medications, n (%) | 4 (3.6) |
| Hemoglobin, g/L | 136.15 ± 13.10 |
| Albumin, g/L | 39.22 ± 3.01 |
| Glucose, mmol/L | 5.2 (4.8–5.9) |
| Tumor classification, n (%) | |
| Meningioma | 43 (39.1) |
| Glioma | 42 (38.2) |
| Acoustic neuroma | 11 (10.0) |
| Other | 14 (12.7) |
| Tumor location, n (%) | |
| Supratentorial | 79 (71.8) |
| Infratentorial | 31 (28.2) |
| Malignant, n (%) | 52 (47.3) |
| Tumor size, cm3 | 43.5 (17.9–95.9) |
| Barthel index | 90 (80–95) |
| PSQI | 6 (3–10) |
| MMSE | 27 (25–29) |
| HADS -anxiety score | 3 (0–5) |
| HADS -depression score | 3 (0–5) |
BMI, body mass index; PSQI, Pittsburgh Sleep Quality Index; MMSE, Mini-Mental State Examination; HADS, Hospital Anxiety and Depression Scale. Data are presented as mean ± standard deviation, median (interquartile range), or frequency (percentage) as appropriate.